mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |